208 related articles for article (PubMed ID: 32845957)
1. Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies.
Kuehn HS; Niemela JE; Stoddard J; Mannurita SC; Shahin T; Goel S; Hintermeyer M; Heredia RJ; Garofalo M; Lucas L; Singh S; Tondo A; Jacobs Z; Gahl WA; Latour S; Verbsky J; Routes J; Cunningham-Rundles C; Boztug K; Gambineri E; Fleisher TA; Chandrakasan S; Rosenzweig SD
Blood; 2021 Jan; 137(3):349-363. PubMed ID: 32845957
[TBL] [Abstract][Full Text] [Related]
2. IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.
Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
J Clin Immunol; 2021 Jan; 41(1):1-10. PubMed ID: 33392855
[TBL] [Abstract][Full Text] [Related]
3. Inborn errors of human IKAROS: LOF and GOF variants associated with primary immunodeficiency.
Kuehn HS; Boast B; Rosenzweig SD
Clin Exp Immunol; 2023 Apr; 212(2):129-136. PubMed ID: 36433803
[TBL] [Abstract][Full Text] [Related]
4. Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding.
Cobb BS; Morales-Alcelay S; Kleiger G; Brown KE; Fisher AG; Smale ST
Genes Dev; 2000 Sep; 14(17):2146-60. PubMed ID: 10970879
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.
Boutboul D; Kuehn HS; Van de Wyngaert Z; Niemela JE; Callebaut I; Stoddard J; Lenoir C; Barlogis V; Farnarier C; Vely F; Yoshida N; Kojima S; Kanegane H; Hoshino A; Hauck F; Lhermitte L; Asnafi V; Roehrs P; Chen S; Verbsky JW; Calvo KR; Husami A; Zhang K; Roberts J; Amrol D; Sleaseman J; Hsu AP; Holland SM; Marsh R; Fischer A; Fleisher TA; Picard C; Latour S; Rosenzweig SD
J Clin Invest; 2018 Jul; 128(7):3071-3087. PubMed ID: 29889099
[TBL] [Abstract][Full Text] [Related]
6. Abnormal SCID Newborn Screening and Spontaneous Recovery Associated with a Novel Haploinsufficiency IKZF1 Mutation.
Kuehn HS; Gloude NJ; Dimmock D; Tokita M; Wright M; Rosenzweig SD; Collins C
J Clin Immunol; 2021 Aug; 41(6):1241-1249. PubMed ID: 33855675
[TBL] [Abstract][Full Text] [Related]
7. Recruitment of ikaros to pericentromeric heterochromatin is regulated by phosphorylation.
Gurel Z; Ronni T; Ho S; Kuchar J; Payne KJ; Turk CW; Dovat S
J Biol Chem; 2008 Mar; 283(13):8291-300. PubMed ID: 18223295
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
[TBL] [Abstract][Full Text] [Related]
9. Germline
Kuehn HS; Nunes-Santos CJ; Rosenzweig SD
Expert Rev Clin Immunol; 2021 Apr; 17(4):407-416. PubMed ID: 33691560
[No Abstract] [Full Text] [Related]
10. Assessing the Functional Relevance of Variants in the
Eskandarian Z; Fliegauf M; Bulashevska A; Proietti M; Hague R; Smulski CR; Schubert D; Warnatz K; Grimbacher B
Front Immunol; 2019; 10():568. PubMed ID: 31057532
[TBL] [Abstract][Full Text] [Related]
11. IKAROS Family Zinc Finger 1-Associated Diseases in Primary Immunodeficiency Patients.
Nunes-Santos CJ; Kuehn HS; Rosenzweig SD
Immunol Allergy Clin North Am; 2020 Aug; 40(3):461-470. PubMed ID: 32654692
[TBL] [Abstract][Full Text] [Related]
12. Expression of dominant-negative and mutant isoforms of the antileukemic transcription factor Ikaros in infant acute lymphoblastic leukemia.
Sun L; Heerema N; Crotty L; Wu X; Navara C; Vassilev A; Sensel M; Reaman GH; Uckun FM
Proc Natl Acad Sci U S A; 1999 Jan; 96(2):680-5. PubMed ID: 9892693
[TBL] [Abstract][Full Text] [Related]
13. Ikaros SUMOylation: switching out of repression.
Gómez-del Arco P; Koipally J; Georgopoulos K
Mol Cell Biol; 2005 Apr; 25(7):2688-97. PubMed ID: 15767674
[TBL] [Abstract][Full Text] [Related]
14. Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Sun L; Goodman PA; Wood CM; Crotty ML; Sensel M; Sather H; Navara C; Nachman J; Steinherz PG; Gaynon PS; Seibel N; Vassilev A; Juran BD; Reaman GH; Uckun FM
J Clin Oncol; 1999 Dec; 17(12):3753-66. PubMed ID: 10577847
[TBL] [Abstract][Full Text] [Related]
15. Sumoylation Inhibits the Growth Suppressive Properties of Ikaros.
Apostolov A; Litim-Mecheri I; Oravecz A; Goepp M; Kirstetter P; Marchal P; Ittel A; Mauvieux L; Chan S; Kastner P
PLoS One; 2016; 11(6):e0157767. PubMed ID: 27315244
[TBL] [Abstract][Full Text] [Related]
16. Multiple functions of Ikaros in hematological malignancies, solid tumor and autoimmune diseases.
Chen Q; Shi Y; Chen Y; Ji T; Li Y; Yu L
Gene; 2019 Feb; 684():47-52. PubMed ID: 30352248
[TBL] [Abstract][Full Text] [Related]
17. A novel, non-canonical splice variant of the Ikaros gene is aberrantly expressed in B-cell lymphoproliferative disorders.
Capece D; Zazzeroni F; Mancarelli MM; Verzella D; Fischietti M; Di Tommaso A; Maccarone R; Plebani S; Di Ianni M; Gulino A; Alesse E
PLoS One; 2013; 8(7):e68080. PubMed ID: 23874502
[TBL] [Abstract][Full Text] [Related]
18. Ikaros stability and pericentromeric localization are regulated by protein phosphatase 1.
Popescu M; Gurel Z; Ronni T; Song C; Hung KY; Payne KJ; Dovat S
J Biol Chem; 2009 May; 284(20):13869-13880. PubMed ID: 19282287
[TBL] [Abstract][Full Text] [Related]
19. A Point Mutation in IKAROS ZF1 Causes a B Cell Deficiency in Mice.
Boast B; Miosge LA; Kuehn HS; Cho V; Athanasopoulos V; McNamara HA; Sontani Y; Mei Y; Howard D; Sutton HJ; Omari SA; Yu Z; Nasreen M; Andrews TD; Cockburn IA; Goodnow CC; Rosenzweig SD; Enders A
J Immunol; 2021 Apr; 206(7):1505-1514. PubMed ID: 33658297
[TBL] [Abstract][Full Text] [Related]
20. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development.
Sun L; Liu A; Georgopoulos K
EMBO J; 1996 Oct; 15(19):5358-69. PubMed ID: 8895580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
